摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3R,4S)-4-{4-[2-(2,6-dichloro-4-methyl-phenoxy)-ethoxy]-phenyl}-piperidine-3-carboxylic acid [2-chloro-5-(2-methoxy-ethyl)-benzyl]-cyclopropyl-amide | 1007392-67-7

中文名称
——
中文别名
——
英文名称
(3R,4S)-4-{4-[2-(2,6-dichloro-4-methyl-phenoxy)-ethoxy]-phenyl}-piperidine-3-carboxylic acid [2-chloro-5-(2-methoxy-ethyl)-benzyl]-cyclopropyl-amide
英文别名
(3R,4S)-N-(2-chloro-5-(2-methoxyethyl)benzyl)-N-cyclopropyl-4-(4-(2-(2,6-dichloro-4-methylphenoxy)ethoxy)phenyl)piperidine-3-carboxamide;(3R,4S)-N-[[2-chloro-5-(2-methoxyethyl)phenyl]methyl]-N-cyclopropyl-4-[4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl]piperidine-3-carboxamide
(3R,4S)-4-{4-[2-(2,6-dichloro-4-methyl-phenoxy)-ethoxy]-phenyl}-piperidine-3-carboxylic acid [2-chloro-5-(2-methoxy-ethyl)-benzyl]-cyclopropyl-amide化学式
CAS
1007392-67-7
化学式
C34H39Cl3N2O4
mdl
——
分子量
646.054
InChiKey
LANNZQCALHSARO-WDYNHAJCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.2
  • 重原子数:
    43
  • 可旋转键数:
    13
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    60
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    (3-(tert-butyldimethylsilanyloxymethyl)-4-chlorobenzyl)-(2,2-difluoroethyl)carbamic acid tert-butyl ester盐酸sodium hydroxide 作用下, 以 1,4-二氧六环二氯甲烷 为溶剂, 反应 6.0h, 以50%的产率得到(3R,4S)-4-{4-[2-(2,6-dichloro-4-methyl-phenoxy)-ethoxy]-phenyl}-piperidine-3-carboxylic acid [2-chloro-5-(2-methoxy-ethyl)-benzyl]-cyclopropyl-amide
    参考文献:
    名称:
    Novel Piperidine Carboxylic Acid Amide Derivatives
    摘要:
    本发明涉及新型的哌啶羧酸酰胺衍生物及其作为活性成分用于制备药物组合物。本发明还涉及相关方面,包括这些新型化合物的制备方法、包含此类化合物的药物组合物,尤其是此类化合物作为肾素抑制剂的应用。
    公开号:
    US20080214598A1
点击查看最新优质反应信息

文献信息

  • Piperidine carboxylic acid amide derivatives
    申请人:Actelion Pharmaceuticals Ltd.
    公开号:US07799805B2
    公开(公告)日:2010-09-21
    The invention relates to novel piperidine carboxylic acid amide derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of these novel compounds, pharmaceutical compositions comprising such compounds and especially the use of such compounds as inhibitors of renin.
    本发明涉及一种新型吡啶基羧酸酰胺衍生物及其用作制备制药组合物的活性成分。本发明还涉及相关方面,包括制备这些新化合物的过程、包含这些化合物的制药组合物,特别是将这些化合物用作肾素抑制剂的用途。
  • NOVEL PIPERIDINE CARBOXYLIC ACID AMINE DERIVATIVES
    申请人:Bezencon Olivier
    公开号:US20100324052A1
    公开(公告)日:2010-12-23
    The invention relates to novel piperidine carboxylic acid amide derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of these novel compounds, pharmaceutical compositions comprising such compounds and especially the use of such compounds as inhibitors of renin.
    本发明涉及新型哌啶羧酸酰胺衍生物及其作为制备药物组合物中的活性成分的用途。本发明还涉及相关方面,包括制备这些新化合物的过程,包含这种化合物的药物组合物,特别是将这种化合物用作肾素抑制剂的用途。
  • Novel Piperidine Carboxylic Acid Amide Derivatives
    申请人:Bezencon Olivier
    公开号:US20080214598A1
    公开(公告)日:2008-09-04
    The invention relates to novel piperidine carboxylic acid amide derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of these novel compounds, pharmaceutical compositions comprising such compounds and especially the use of such compounds as inhibitors of renin.
    本发明涉及新型的哌啶羧酸酰胺衍生物及其作为活性成分用于制备药物组合物。本发明还涉及相关方面,包括这些新型化合物的制备方法、包含此类化合物的药物组合物,尤其是此类化合物作为肾素抑制剂的应用。
查看更多